Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Cellular and Animal Models of Striated Muscle Laminopathies.

Nicolas HA, Akimenko MA, Tesson F.

Cells. 2019 Mar 29;8(4). pii: E291. doi: 10.3390/cells8040291. Review.

2.

ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study.

Rajkumar A, Liaghati A, Chan J, Lamothe G, Dent R, Doucet É, Rabasa-Lhoret R, Prud'homme D, Harper ME, Tesson F.

Metabolism. 2018 Jun;83:271-279. doi: 10.1016/j.metabol.2018.03.019. Epub 2018 Mar 29.

PMID:
29605434
4.

Lamin A/C mutations in dilated cardiomyopathy.

Tesson F, Saj M, Uvaize MM, Nicolas H, Płoski R, Bilińska Z.

Cardiol J. 2014;21(4):331-42. doi: 10.5603/CJ.a2014.0037. Epub 2014 May 20. Review.

PMID:
24846508
5.

LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.

Saj M, Bilinska ZT, Tarnowska A, Sioma A, Bolongo P, Sobieszczanska-Malek M, Michalak E, Golen D, Mazurkiewicz L, Malek L, Walczak E, Fidzianska A, Grzybowski J, Przybylski A, Zielinski T, Korewicki J, Tesson F, Ploski R.

BMC Med Genet. 2013 May 23;14:55. doi: 10.1186/1471-2350-14-55.

6.

The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women.

Cameron JD, Riou MÈ, Tesson F, Goldfield GS, Rabasa-Lhoret R, Brochu M, Doucet É.

Appetite. 2013 Jan;60(1):111-116. doi: 10.1016/j.appet.2012.09.010. Epub 2012 Sep 29.

7.

Lamin A/C mutants disturb sumo1 localization and sumoylation in vitro and in vivo.

Boudreau É, Labib S, Bertrand AT, Decostre V, Bolongo PM, Sylvius N, Bonne G, Tesson F.

PLoS One. 2012;7(9):e45918. doi: 10.1371/journal.pone.0045918. Epub 2012 Sep 21.

8.

Variants of the lamin A/C (LMNA) gene in non-valvular atrial fibrillation patients: a possible pathogenic role of the Thr528Met mutation.

Saj M, Dabrowski R, Labib S, Jankowska A, Szperl M, Broda G, Szwed H, Tesson F, Bilinska ZT, Ploski R.

Mol Diagn Ther. 2012 Apr 1;16(2):99-107. doi: 10.2165/11597540-000000000-00000.

PMID:
22413764
9.

Effects of exercise training on molecular markers of lipogenesis and lipid partitioning in fructose-induced liver fat accumulation.

Yasari S, Prud'homme D, Tesson F, Jankowski M, Gutkowska J, Levy E, Lavoie JM.

J Nutr Metab. 2012;2012:181687. doi: 10.1155/2012/181687. Epub 2011 Aug 10.

10.

Enhanced expression of epithelial sodium channels in the renal medulla of Dahl S rats.

Amin MS, Reza E, El-Shahat E, Wang HW, Tesson F, Leenen FH.

Can J Physiol Pharmacol. 2011 Mar;89(3):159-68. doi: 10.1139/Y11-005.

PMID:
21423289
11.

A new c.1621 C > G, p.R541G lamin A/C mutation in a family with DCM and regional wall motion abnormalities (akinesis/dyskinesis): genotype-phenotype correlation.

Małek LA, Labib S, Mazurkiewicz L, Saj M, Płoski R, Tesson F, Bilińska ZT.

J Hum Genet. 2011 Jan;56(1):83-6. doi: 10.1038/jhg.2010.137. Epub 2010 Nov 18.

PMID:
21085127
12.

Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.

Gupta P, Bilinska ZT, Sylvius N, Boudreau E, Veinot JP, Labib S, Bolongo PM, Hamza A, Jackson T, Ploski R, Walski M, Grzybowski J, Walczak E, Religa G, Fidzianska A, Tesson F.

Basic Res Cardiol. 2010 May;105(3):365-77. doi: 10.1007/s00395-010-0085-4. Epub 2010 Feb 3.

13.

Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.

Paczkowska A, Szperl M, Małek Ł, Mazurkiewicz Ł, Skóra E, Grzybowski J, Roszczynko M, Bilińska Z, Tesson F, Ruzyłło W.

Kardiol Pol. 2009 Mar;67(3):235-41.

PMID:
19378229
14.

Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss.

Teng AC, Adamo K, Tesson F, Stewart AF.

FASEB J. 2009 Jun;23(6):1705-9. doi: 10.1096/fj.08-120998. Epub 2009 Feb 13.

15.

Gene-environment interaction and the metabolic syndrome.

Adamo KB, Tesson F.

Novartis Found Symp. 2008;293:103-19; discussion 119-27. Review.

PMID:
18972748
16.

Specific contribution of lamin A and lamin C in the development of laminopathies.

Sylvius N, Hathaway A, Boudreau E, Gupta P, Labib S, Bolongo PM, Rippstein P, McBride H, Bilinska ZT, Tesson F.

Exp Cell Res. 2008 Aug 1;314(13):2362-75. doi: 10.1016/j.yexcr.2008.04.017. Epub 2008 May 10.

17.

Obliteration of cardiomyocyte nuclear architecture in a patient with LMNA gene mutation.

Fidziańska A, Bilińska ZT, Tesson F, Wagner T, Walski M, Grzybowski J, Ruzyłło W, Hausmanowa-Petrusewicz I.

J Neurol Sci. 2008 Aug 15;271(1-2):91-6. doi: 10.1016/j.jns.2008.03.017. Epub 2008 May 27.

PMID:
18502446
18.

Still building on candidate-gene strategy in hypertension?

Tesson F, Leenen FH.

Hypertension. 2007 Oct;50(4):607-8. Epub 2007 Aug 20. No abstract available.

20.

Genotype-specific weight loss treatment advice: how close are we?

Adamo KB, Tesson F.

Appl Physiol Nutr Metab. 2007 Jun;32(3):351-66. Review.

PMID:
17510669
21.

Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response.

Adamo KB, Dent R, Langefeld CD, Cox M, Williams K, Carrick KM, Stuart JS, Sundseth SS, Harper ME, McPherson R, Tesson F.

Obesity (Silver Spring). 2007 May;15(5):1068-75.

22.

Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.

Bilińska ZT, Sylvius N, Grzybowski J, Fidziańska A, Michalak E, Walczak E, Walski M, Bieganowska K, Szymaniak E, Kuśmierczyk-Droszcz B, Lubiszewska B, Wagner T, Tesson F, Ruzyłło W.

Kardiol Pol. 2006 Aug;64(8):812-9; discussion 820-1.

PMID:
16981056
23.

Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation.

Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, Tesson F, Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara L, Bai D.

N Engl J Med. 2006 Jun 22;354(25):2677-88.

24.

Lamin A/C and cardiac diseases.

Sylvius N, Tesson F.

Curr Opin Cardiol. 2006 May;21(3):159-65. Review.

PMID:
16601451
25.

In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.

Sylvius N, Bilinska ZT, Veinot JP, Fidzianska A, Bolongo PM, Poon S, McKeown P, Davies RA, Chan KL, Tang AS, Dyack S, Grzybowski J, Ruzyllo W, McBride H, Tesson F.

J Med Genet. 2005 Aug;42(8):639-47.

26.

Influence of Pro12Ala peroxisome proliferator-activated receptor gamma2 polymorphism on glucose response to exercise training in type 2 diabetes.

Adamo KB, Sigal RJ, Williams K, Kenny G, Prud'homme D, Tesson F.

Diabetologia. 2005 Aug;48(8):1503-9. Epub 2005 Jun 29.

PMID:
15986237
27.

Decreased mitochondrial proton leak and reduced expression of uncoupling protein 3 in skeletal muscle of obese diet-resistant women.

Harper ME, Dent R, Monemdjou S, Bézaire V, Van Wyck L, Wells G, Kavaslar GN, Gauthier A, Tesson F, McPherson R.

Diabetes. 2002 Aug;51(8):2459-66.

28.

A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16.

Sylvius N, Tesson F, Gayet C, Charron P, Bénaïche A, Peuchmaurd M, Duboscq-Bidot L, Feingold J, Beckmann JS, Bouchier C, Komajda M.

Am J Hum Genet. 2001 Jan;68(1):241-6. Epub 2000 Nov 20.

29.

Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy.

Tesson F, Sylvius N, Pilotto A, Dubosq-Bidot L, Peuchmaurd M, Bouchier C, Benaiche A, Mangin L, Charron P, Gavazzi A, Tavazzi L, Arbustini E, Komajda M.

Eur Heart J. 2000 Nov;21(22):1872-6.

PMID:
11052860
30.

Familial dilated cardiomyopathy: clinical features in French families.

Mangin L, Charron P, Tesson F, Mallet A, Dubourg O, Desnos M, Benaïsche A, Gayet C, Gibelin P, Davy JM, Bonnet J, Sidi D, Schwartz K, Komajda M.

Eur J Heart Fail. 1999 Dec;1(4):353-61.

31.

Genetic aspects of heart failure.

Komajda M, Charron P, Tesson F.

Eur J Heart Fail. 1999 Jun;1(2):121-6. Review.

32.

Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group.

Charron P, Tesson F, Poirier O, Nicaud V, Peuchmaurd M, Tiret L, Cambien F, Amouyel P, Dubourg O, Bouhour J, Millaire A, Juilliere Y, Bareiss P, André-Fouët X, Pouillart F, Arveiler D, Ferrières J, Dorent R, Roizès G, Schwartz K, Desnos M, Komajda M.

Eur Heart J. 1999 Nov;20(21):1587-91.

PMID:
10529327
33.

Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group.

Tesson F, Charron P, Peuchmaurd M, Nicaud V, Cambien F, Tiret L, Poirier O, Desnos M, Jullières Y, Amouyel P, Roizès G, Dorent R, Schwartz K, Komajda M.

J Mol Cell Cardiol. 1999 May;31(5):1025-32.

PMID:
10336842
34.

Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A, Komajda M.

Eur Heart J. 1999 Jan;20(2):93-102. Review. No abstract available.

PMID:
10099905
35.

Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.

Tesson F, Richard P, Charron P, Mathieu B, Cruaud C, Carrier L, Dubourg O, Lautié N, Desnos M, Millaire A, Isnard R, Hagege AA, Bouhour JB, Bennaceur M, Hainque B, Guicheney P, Schwartz K, Komajda M.

Hum Mutat. 1998;12(6):385-92.

PMID:
9829907
36.

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children.

Charron P, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagege A, Carrier L, Bonne G, Tesson F, Richard P, Hainque B, Schwartz K, Komajda M.

Eur Heart J. 1998 Sep;19(9):1377-82.

PMID:
9792264
37.

Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes.

Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Bonne G, Carrier L, Tesson F, Bouhour JB, Buzzi JC, Feingold J, Schwartz K, Komajda M.

Eur Heart J. 1998 Jan;19(1):139-45.

PMID:
9503187
38.

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population.

Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Millaire A, Carrier L, Bonne G, Tesson F, Richard P, Bouhour JB, Schwartz K, Komajda M.

Circulation. 1997 Jul 1;96(1):214-9.

PMID:
9236436
39.

The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation.

Tesson F, Dufour C, Moolman JC, Carrier L, al-Mahdawi S, Chojnowska L, Dubourg O, Soubrier E, Brink P, Komajda M, Guicheney P, Schwartz K, Feingold J.

J Mol Cell Cardiol. 1997 Feb;29(2):831-8.

PMID:
9140839
40.

A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome.

Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Fauré S, Gary F, Coumel P, Petit C, Schwartz K, Guicheney P.

Nat Genet. 1997 Feb;15(2):186-9.

PMID:
9020846
41.

Penetrance of familial hypertrophic cardiomyopathy.

Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne G, Guicheney P, Hainque B, Bouhour JB, Mallet A, Feingold J, Schwartz K, Komajda M.

Genet Couns. 1997;8(2):107-14.

PMID:
9219008
42.

Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-Nielsen syndrome.

Tesson F, Donger C, Denjoy I, Berthet M, Bennaceur M, Petit C, Coumel P, Schwarts K, Guicheney P.

J Mol Cell Cardiol. 1996 Sep;28(9):2051-5.

PMID:
8899564
43.
44.

Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.

Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tomé FM, Schwartz K, Fardeau M, Tryggvason K, et al.

Nat Genet. 1995 Oct;11(2):216-8.

PMID:
7550355
45.

Evidence for a role for imidazoline I1 binding site in rat brown adipocytes.

Mory G, Tesson F, Combes-George M, Nechad M, Parini A.

Ann N Y Acad Sci. 1995 Jul 12;763:398-400. No abstract available.

PMID:
7677352
46.

Localization of I2-imidazoline binding sites on monoamine oxidases.

Tesson F, Limon-Boulez I, Urban P, Puype M, Vandekerckhove J, Coupry I, Pompon D, Parini A.

J Biol Chem. 1995 Apr 28;270(17):9856-61.

47.

Cell-associated and soluble phospholipases A2 increase during carrageenan and zymosan-induced pleurisy in rat.

Tesson F, Ruffié C, Hidi R, e Silva PM, Vazeux G, Vargaftig BB, Bon C.

Eur J Pharmacol. 1993 Jun 1;248(1):27-32. Erratum in: Eur J Pharmacol 1993 Dec 1;248(4):351.

PMID:
8339752
48.

[Imidazoline-guanidine site: a subtype of imidazoline receptors].

Coupry I, Limon I, Tesson F, Lachaud V, Gargalidis-Moudanos C, Parini A.

Therapie. 1992 Nov;47(6):519-24. Review. French.

PMID:
1338740
49.

Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites.

Tesson F, Limon I, Parini A.

Eur J Pharmacol. 1992 Aug 25;219(2):335-8.

PMID:
1425960
50.

Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.

Lachaud V, Limon I, Tesson F, Coupry I, Parini A.

Am J Hypertens. 1992 Apr;5(4 Pt 2):69S-71S.

PMID:
1350730

Supplemental Content

Loading ...
Support Center